Jie Chen

Dr. Jie Chen

Department of Rheumatology and Immunology, Affiliated Hospital of Southwest Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
YHYue He
Yue He
YDYujiao Dan
Yujiao Dan
XGXiaorong Gao
Xiaorong Gao
LHLi Huang
Li Huang
HLHongbin Lv
Hongbin Lv
JCJie Chen
Jie Chen
Diabetic retinopathy (DR) is one of the serious complications that occurs in diabetic patients that frequently causes blindness. Long noncoding RNAs (lncRNAs) have been associated with DR pathology. This study aimed to determine the underlying mechanism of lncRNA maternally expressed gene 3 (MEG3) in association with DNA methyltransferase 1 (DNMT1) in the endothelial-mesenchymal transition (endMT) that occurs in DR. A rat model of DR was induced by streptozotocin (STZ) injection, and a high-glucose (HG)-induced cell model was established by exposing microvascular endothelial cells obtained from retina of rats to HG. Subsequently, MEG3 was overexpressed in rat and cell models to characterize its impact on endMT in DR and the involvement of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway. Furthermore, the methylation level of MEG3 promoter region was determined with the application of methylation-specific polymerase chain reaction, followed by chromatin immunoprecipitation assay for methyltransferase enrichment. Finally, we examined the regulation of DNMT1 on MEG3 methylation and endMT in the HG-induced cell model. The results obtained revealed downregulated MEG3 expression in DR rat and cell models. Overexpressed MEG3 was shown to suppress endMT in DR rat and cell models through the inhibition of the PI3K/Akt/mTOR signaling pathway. Notably, DNMT1 could promote MEG3 promoter methylation to inhibit MEG3 expression by recruiting methyltransferase, which activated the PI3K/Akt/mTOR signaling pathway to accelerate endMT in DR. These findings further highlighted the inhibitory effect of MEG3 on endMT in DR, thus presenting a novel therapeutic target candidate for DR treatment.

20 January 2021 in RNA Biology
Verified
Journal Article
Closed access
JCJie Chen
Jie Chen
XLXiao Luo
Xiao Luo
MLMao Liu
Mao Liu
LPLihui Peng
Lihui Peng
ZZZixia Zhao
Zixia Zhao
YHYue He
Yue He
The participation of long noncoding RNAs (lncRNAs) and microRNAs (miRs) in the progression of rheumatoid arthritis (RA) is a key area of investigation. The current study aimed to investigate the action of lncRNA nuclear paraspeckle assembly transcript 1 (NEAT1) in fibroblast-like synoviocyte (FLS) proliferation and synovitis in RA. A rat model of RA was established. LncRNA NEAT1 expression in the synovial tissues of patients with RA and FLSs from the RA rat model was determined using RT-qPCR. Next, dual luciferase reporter gene assay was applied to investigate the relationship between miR-129/204 and mitogen-activated protein kinase (MAPK)/extracellular regulated protein kinase (ERK). A putative binding relationship between miR-204 and lncRNA NEAT1 was evaluated by RIP assay, and miR-129 promoter methylation was determined using MSP. After the expression of lncRNA NEAT1, miR-129 or miR-204 were altered in FLSs, the extent of ERK1/2 phosphorylation was assessed. In addition, FLS synovitis and proliferation were determined by ELISA and EdU assay, respectively. In RA rats, lncRNA NEAT1 was silenced and miR-129/miR-204 was overexpressed to explore their roles in vivo. LncRNA NEAT1 was upregulated, while miR-129 and miR-204 were downregulated in RA synovial tissues and FLSs. MAPK1 was target gene of both miR-129 and miR-204. LncRNA NEAT1 bound to miR-204 and promoted miR-129 promoter methylation. Silencing lncRNA NEAT1 or overexpressing miR-129/miR-204 enhanced miR-129/miR-204 expression, but reduced the extent of ERK1/2 phosphorylation, proliferation of FLSs, and synovitis in RA. Collectively, silencing lncRNA NEAT1 promoted miR-129 and miR-204 to inhibit the MAPK/ERK signaling pathway, reducing FLS synovitis in RA.

30 March 2021 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
ZZZi-Xia Zhao
Zi-Xia Zhao
YHYue He
Yue He
LPLi-Hui Peng
Li-Hui Peng
XLXiao Luo
Xiao Luo
MLMao Liu
Mao Liu
JCJie Chen
Jie Chen

1 April 2021 in Cellular Immunology
Verified
Journal Article
Closed access
JCJie Chen
Jie Chen
LPLihui Peng
Lihui Peng
ZZZixia Zhao
Zixia Zhao
QYQiuyu Yang
Qiuyu Yang
FYFeng Yin
Feng Yin
YHYue He
Yue He

1 April 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
YHYue He
Yue He
ZZZhiru Zhang
Zhiru Zhang
TYTianyu Yao
Tianyu Yao
LHLi Huang
Li Huang
JGJinhua Gan
Jinhua Gan
JCJie Chen
Jie Chen

7 April 2021 in Expert Review of Anticancer Therapy
Verified
Journal Article
Closed access
JCJie Chen
Jie Chen
YLYi Liao
Yi Liao
XFXian-Ming Fan
Xian-Ming Fan
Abnormal BUB1B expression has been proven to be related to the poor prognosis of various tumors. This meta-analysis aimed to identify the prognostic role of BUB1B in patients with lung adenocarcino...